Ronald Burggrave

Ronald Burggrave has over 25 years of experiences in developing and executing marketing and sales strategies of innovative life sciences technologies.

Current
PiEXT BV - director:
Sales, Marketing and Business Development Consultant.
Agent for Start-Up Companies.
Principals
Genetic Signatures

Genetic Signatures Ltd, Sydney, Australia
Transforming Molecular Diagnostics: novel tools for pathogen screening.
WebSite: www.geneticsignatures.com

Personalis

Personalis' Exome Sequencing, for genome guided medicine.
Sr Account Executive for the BNL.
WebSite: www.personalis.com
OpGen

OpGen INC, Whole Genome Optical Mapping Products and Services
Exclusive dealer for OpGen's technology.
WebSite: www.opgen.com

Biolegio

Biolegio BV, Nijmegen, the Netherlands: Custom Made Oligos and Probes.
WebSite: www.biolegio.com

Contact details and information

Piext B.V.
Maliskampsestraat 6
5248 AD Rosmalen
The Netherlands
+31 (0)6 21 929 402
ronald@piext.nl

Chamber of Commerce: 172.00.289
IBAN ING-Bank: NL65INGB067 33 34 147
VAT-id-nr: NL8174.19.275B.01
EORI-nr: NL8174.19.275

Projects

LA Screen, a RvO (AgentschapNL) funded project, to develop a methodology
to characterize (detect and type) pathogenic bacteria in the food chain.
Concluded Spring 2014.
WebSite: Plos1 LA-MRSA

PathoNGenTrace, a EU FP7 research project:
Next Generation Genome Based High Resolution Tracing of Pathogens.
Website: PNGT